Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke Among Japanese Men and Women
2007
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers
2016
Mangiferin: a natural miracle bioactive compound against lifestyle related disorders
2017 Standout
Flax and flaxseed oil: an ancient medicine & modern functional food
2014 Standout
Definition of the Metabolic Syndrome: What's New and What Predicts Risk?
2006
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
2017 Standout
The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: Results of a 15 years follow-up in a Mediterranean population
2007
Triglycerides and Cardiovascular Disease
2011
Rheumatoid arthritis
2018 Standout
Waist‐to‐height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta‐analysis
2011 Standout
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
2015 Standout
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference?
2007
A global view of pulmonary hypertension
2016 Standout
A lipid-parameter-based index for estimating insulin sensitivity and identifying insulin resistance in a healthy population
2008
Bipolar Disorder and the Metabolic Syndrome
2008
Metabolic Aspects of Bariatric Surgery
2007
Is There an Obesity Paradox After Percutaneous Coronary Intervention in the Contemporary Era?
2010
The metabolic syndrome and incidence of cardiovascular disease in non‐diabetic subjects—a population‐based study comparing three different definitions
2007
All-Cause and Cardiovascular Mortality Using the Different Definitions of Metabolic Syndrome
2008
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Global Public Health Burden of Heart Failure
2017 Standout
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
2011
Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm
2007
The global NAFLD epidemic
2013 Standout
Pathophysiology and epidemiology of abdominal aortic aneurysms
2010 Standout
ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial
2011
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study
2007
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
The emerging role of HDL in glucose metabolism
2012
The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality
2007
Chronic Intermittent Hypoxia Induces Atherosclerosis via Activation of Adipose Angiopoietin-like 4
2013 StandoutNobel
Overweight, cardiovascular diseases and diabetes
2012
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Association of Plasma Resistin With Glomerular Filtration Rate and Albuminuria in Hypertensive Adults
2007
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Effects of PREMIER Lifestyle Modifications on Participants With and Without the Metabolic Syndrome
2007
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
The Lymphatic System: Integral Roles in Immunity
2016 Standout
Contemporary aetiology, clinical characteristics and prognosis of adults with heart failure observed in a tertiary hospital in Tanzania: the prospective Tanzania Heart Failure (TaHeF) study
2014
Abdominal Aortic Aneurysm Repair in Obese Patients: Improved Outcome After Endovascular Treatment Compared With Open Surgery
2009
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
2014
The Alpha Linolenic Acid Content of Flaxseed is Associated with an Induction of Adipose Leptin Expression
2011
Secretion of adipokines by human adipose tissue in vivo: partitioning between capillary and lymphatic transport
2011
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies.
2007
Modulation of Diabetes and Dyslipidemia in Diabetic Insulin-Resistant Rats by Mangiferin: Role of Adiponectin and TNF-α
2014
The Metabolic Syndrome
2008 Standout
Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus
2015
Obesity, Adipokines, and Abdominal Aortic Aneurysm
2007
Inclusion of Stroke in Cardiovascular Risk Prediction Instruments
2012
Impact of Insulin Resistance on Risk of Type 2 Diabetes and Cardiovascular Disease in People With Metabolic Syndrome
2007
Works of Thomas Marte being referenced
Leptin, leptin soluble receptor and coronary atherosclerosis
2007
Impact of total and central obesity on vascular mortality in patients undergoing coronary angiography
2005
Evaluation of two fully automated novel enzyme-linked immunosorbent assays for the determination of human adiponectin in serum
2006
Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis
2009
Effectiveness of Atrial Fibrillation as an Independent Predictor of Death and Coronary Events in Patients Having Coronary Angiography
2008
The Metabolic Syndrome, Insulin Resistance, and Cardiovascular Risk in Diabetic and Nondiabetic Patients
2005
Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function
2006
The –11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men
2007
Adult Treatment Panel III 2001 but Not International Diabetes Federation 2005 Criteria of the Metabolic Syndrome Predict Clinical Cardiovascular Events in Subjects Who Underwent Coronary Angiography
2006
Diabetes as a coronary artery disease risk equivalent: before a change of paradigm?
2010
Is Atherosclerosis in Diabetes and Impaired Fasting Glucose Driven by Elevated LDL Cholesterol or by Decreased HDL Cholesterol?
2005